Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
82 hedge funds and large institutions have $70.9M invested in Genesis Healthcare, Inc. in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 15 reducing their positions, and 4 closing their positions.
375% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 4
113% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 15
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
57% more capital invested
Capital invested by funds: $45M → $70.9M (+$25.8M)
22% more funds holding
Funds holding: 67 → 82 (+15)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.67M |
| 2 |
BlackRock
New York
|
+$1.65M |
| 3 |
JP Morgan Chase
New York
|
+$1.61M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.38M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$6.57M |
| 2 |
FM
Forward Management
San Francisco,
California
|
-$588K |
| 3 |
Millennium Management
New York
|
-$380K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$269K |
| 5 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$193K |
GEN Hedge Fund Activity: Q2 2018 in Review
82 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q2 2018, worth a combined $70.9M — up 57% from $45M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new GEN positions and 4 closed out — a net gain of 15 holders — while 32 added to existing stakes and 15 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.67M. The largest seller was Columbia Pacific Advisors, cutting an estimated $6.57M.
- 82 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q2 2018, up from 67 in Q1 2018.
- Funds reported $70.9M of Genesis Healthcare, Inc. stock for Q2 2018, up 57% quarter-over-quarter.
- 19 funds opened new Genesis Healthcare, Inc. positions in Q2 2018 and 4 closed out, a net change of +15 holders.
- The largest Genesis Healthcare, Inc. buyer in Q2 2018 was Renaissance Technologies, an estimated $1.67M added.
- The largest Genesis Healthcare, Inc. seller in Q2 2018 was Columbia Pacific Advisors, an estimated $6.57M sold.
Based on aggregated 13F filings for Q2 2018.